title: Chemoprevention of DMBA-induced mammary gland carcinogenesis--preventive effects of free oxygen radical scavengers.
abstract: This study was carried out to determine the effects of Mangan-Desferrioxamine (Mn-DFX) and Verapamil (VRP) in 7,12-dimethyl-benz-[a]anthracene (DMBA) induced mammary carcinoma. 70 Spraque Dawley rats were divided into four groups; as DMBA alone, DMBA + Mn-DFX, DMBA + VRP, and control. Incidence, multiplicity, and size of tumors were evaluated in addition to analyses of DNA ploidy status and proliferation index by flow cytometric technique. The results revealed that Mn-DFX and VRP caused significant decreases in tumor incidence (p < 0.02 and p < 0.05), multiplicity (p < 0.02 and p < 0.05), size (p < 0.05 and p < 0.02), and proliferation index (p < 0.05 and p < 0.02) without any toxic effect. The appearance of first tumors in Mn-DFX and VRP groups was also later than in the DMBA alone group (10th and 11th week versus 6th week). In conclusion, Mn-DFX and VRP have offered prevention in experimental mammary carcinogenesis. These agents caused slower tumor growth, though they could not achieve a complete prevention.
authors.affiliation: Oncology Institute of Istanbul Medical School, Taksim State Hospital 1. Surgical Clinic, Turkey.
authors.forename: G
authors.initials: G
authors.lastname: Soybir
authors.forename: F
authors.initials: F
authors.lastname: Köksoy
authors.forename: H
authors.initials: H
authors.lastname: Koyuncu
authors.forename: O
authors.initials: O
authors.lastname: Yalçin
authors.forename: H
authors.initials: H
authors.lastname: Köse
authors.forename: C
authors.initials: C
authors.lastname: Topuzlu
mesh_terms: D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002273:Carcinogens; D003676:Deferoxamine / Q000627:therapeutic use*; D005260:Female; D016166:Free Radical Scavengers / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D016588:Anticarcinogenic Agents; D002121:Calcium Channel Blockers; D002273:Carcinogens; D016166:Free Radical Scavengers; D009942:Organometallic Compounds; C111813:mangan-desferrioxamin; D015127:9,10-Dimethyl-1,2-benzanthracene; D014700:Verapamil; D003676:Deferoxamine